Limited Period Offer: Get up to 10% off + extra 15% off on medicines & more offers. Explore
(0) Write a review
In stock

Biolide Effective Daily Injection Liraglutide Weight Loss Pen

Prijsklasse: €110.99 tot €199.99

202 people are viewing this right now

Biolide® Daily Injection (Liraglutide) is a prescription GLP-1 medication used to support weight management in eligible adults. Delivered through a once-daily injection pen, it helps regulate appetite and should be used alongside a reduced-calorie diet and increased physical activity under medical supervision. Available through licensed healthcare providers in the UK and across Europe, including Germany, the Netherlands, Norway, Poland, and Spain.

Buy now
  • Free Shipping Icon SVG Vector & PNG Free Download | UXWingFree Shipping & Returns on this item
  • Delivery within 3-5 working days
  • Money Back Guarantee

Description

Biolide® Daily Injection Liraglutide Weight Loss Pen is a prescription weight management treatment designed for adults who are overweight or living with obesity and who may benefit from medical support alongside a reduced-calorie diet and increased physical activity. Administered as a once-daily injection, liraglutide belongs to a class of medicines known as GLP-1 receptor agonists, which work by helping regulate appetite and food intake.

Biolide® is intended to be used under the supervision of a qualified healthcare professional. Treatment suitability, dosing schedules, and expected outcomes vary depending on individual health circumstances and medical history.

How Biolide® (Liraglutide) Works

Liraglutide mimics the action of a naturally occurring hormone called glucagon-like peptide-1 (GLP-1). This hormone helps regulate hunger signals, promotes feelings of fullness after eating, and may help reduce overall calorie intake. When combined with healthy lifestyle changes, liraglutide may support long-term weight management goals.

Key Features

  • Prescription-only weight management medication
  • Once-daily injectable pen for convenient administration
  • Contains liraglutide, a GLP-1 receptor agonist
  • Designed to support appetite regulation
  • Used alongside dietary and lifestyle modifications
  • Pre-filled injection pen format
  • Healthcare professional supervision required

Who May Be Eligible?

Biolide® may be prescribed for adults who:

  • Have a Body Mass Index (BMI) indicating obesity
  • Are overweight and have weight-related health conditions
  • Require additional support in achieving sustainable weight management goals

Eligibility criteria vary by country and healthcare provider. A medical assessment is required before treatment can begin.

Important Safety Information

Biolide® is a prescription medicine and is not suitable for everyone. Patients should discuss their complete medical history, current medications, and any existing health conditions with a healthcare professional before starting treatment. Always follow the prescribed dosing instructions and read the patient information leaflet provided with the medication.

Biolide® Daily Injection (Liraglutide) Weight Loss Pen in the UK, Germany, Netherlands, Norway, Poland, and Spain

Looking for information about Biolide® Daily Injection (Liraglutide) Weight Loss Pen in the United Kingdom, Germany, Netherlands, Norway, Poland, and Spain? Biolide® contains liraglutide, a prescription GLP-1 receptor agonist used as part of a medically supervised weight management program. Administered once daily, it is designed to help regulate appetite and support healthier eating habits when combined with lifestyle changes.

Patients across Europe seeking professional weight management support may discuss liraglutide treatment options with qualified healthcare providers. Biolide® is supplied in a convenient pre-filled injection pen and should only be used according to medical advice and local prescribing guidelines.

Aanvullende informatie

Pack size

3 pens, 5 pens

Biolide FAQs

Biolide is a daily injectable medication containing liraglutide, a GLP-1 receptor agonist that mimics the natural gut hormone GLP-1. It slows stomach emptying, reduces appetite signals in the brain, and improves how your body manages blood sugar. Taken once daily as a self-administered injection pen, Biolide helps eligible adults achieve sustained weight loss when combined with diet and lifestyle changes.

Biolide and Saxenda both contain the same active ingredient — liraglutide — and work in identical ways. The main difference is brand and pricing. Biolide is offered as a more affordable liraglutide alternative starting at €110.99, compared to Saxenda starting at €375.00. Clinical effects and dosing schedules are the same; your doctor will recommend the most appropriate option for your situation.

Biolide is appropriate for adults with a BMI of 30 or above, or a BMI of 27 or above with at least one weight-related condition such as type 2 diabetes, high blood pressure, sleep apnoea, or cardiovascular disease. Eligibility is confirmed by a licensed European doctor during your free online consultation. Contraindications include personal/family history of medullary thyroid cancer (MTC) and MEN 2 syndrome.

Biolide uses a 5-week daily titration to reach the maintenance dose: Week 1 = 0.6 mg daily, Week 2 = 1.2 mg, Week 3 = 1.8 mg, Week 4 = 2.4 mg, Week 5 onwards = 3.0 mg (maintenance). Your doctor may extend any step if side effects are bothersome. If you cannot tolerate 3.0 mg, treatment is usually discontinued — lower doses don't produce significant weight loss.

As Biolide contains liraglutide, expect similar results to Saxenda: average weight loss of 8–12% of starting body weight over 56 weeks at the full 3.0 mg maintenance dose. Approximately 33% of patients lose more than 10% of body weight. Individual results depend on starting weight, adherence to lifestyle changes, and biological response.

Biolide is administered as a once-daily subcutaneous injection in your abdomen, thigh, or upper arm using the pre-filled multi-dose pen. The needle is very thin and barely felt. Take it at the same time each day for consistent effect — many patients prefer morning to avoid disrupting sleep. Rotate injection sites to prevent skin irritation.

The most common side effects are gastrointestinal: nausea (~39% during titration), diarrhoea, constipation, vomiting, and reduced appetite (intended effect). Most resolve within 2–4 weeks of each dose increase. Other effects include headache, fatigue, and mild injection-site reactions. Serious side effects like pancreatitis are rare but require immediate medical attention.

Reduced appetite is typically noticed within the first 1–2 weeks of treatment. Visible weight loss generally begins around week 4 as you approach the full 3.0 mg dose. Most weight loss occurs in the first 6 months. If you haven't lost at least 4% of body weight after 12 weeks at full dose, your doctor may recommend trying a different treatment.

Prioritise lean protein, vegetables, whole grains, and adequate hydration (~2 L water daily). Eat smaller, more frequent meals to manage fullness and reduce nausea. Avoid greasy, fried, or very rich foods especially during titration and after each dose increase. A Mediterranean-style diet works well alongside Biolide for sustainable results.

If you miss your daily dose, take it as soon as you remember on the same day. If you remember the next day, skip the missed dose and continue your normal schedule. Do NOT take a double dose to catch up. If you miss doses for 3 or more consecutive days, contact your doctor — you may need to re-titrate from a lower dose.

Store unopened Biolide pens in the refrigerator at 2–8 °C in the original packaging, away from light. Do not freeze. After first use, pens can be kept at room temperature (below 30 °C) for up to 30 days. Discard after 30 days even if medication remains. Always check the solution before injecting — discard if cloudy or contains particles.

Biolide is not recommended during pregnancy, while trying to conceive, or while breastfeeding. Stop Biolide at least 1 month before planned conception. If you use oral hormonal birth control, slowed gastric emptying may affect absorption — discuss backup contraception with your doctor for at least 4 weeks after starting and after each dose increase.

Weight regain is common after stopping any GLP-1 medication. Most patients regain a significant portion of lost weight within 12 months of stopping. Long-term continuation, transitioning to lifestyle-only management with doctor support, or switching to a weekly GLP-1 like Wegovy are all options your doctor can discuss when you're ready.

Biolide is generally not covered by Dutch basisverzekering for weight management. Some supplementary insurance may offer partial reimbursement — check with your zorgverzekeraar. Our pricing for Biolide is significantly more affordable than Saxenda for the same active ingredient (liraglutide), making it a budget-friendly daily GLP-1 option.

Yes — EU Slim Store ships Biolide to the Netherlands (2–3 days via PostNL), Belgium (2–4 days), UK (1–2 days), Germany (3–5 days), France (3–5 days), Poland (4–5 days), Norway (4–6 days), and other EU countries. All medications are dispensed from an EU-regulated pharmacy in temperature-controlled, discreet packaging.

Reviews

Be the first to review “Biolide Effective Daily Injection Liraglutide Weight Loss Pen”

Je e-mailadres wordt niet gepubliceerd. Vereiste velden zijn gemarkeerd met *

There are no reviews yet.

Search

Back to Top

Shipping Address

Product has been added to your cart
Compare (0)